CZ2015896A3 - The solid forms of the ethyl ester of (2R,4S)-5-(biphenyl-4-yl)-4-[3-carboxy-propionyl)amino]-2—methylpentanoic acid, its salts and the method of its preparation - Google Patents
The solid forms of the ethyl ester of (2R,4S)-5-(biphenyl-4-yl)-4-[3-carboxy-propionyl)amino]-2—methylpentanoic acid, its salts and the method of its preparation Download PDFInfo
- Publication number
- CZ2015896A3 CZ2015896A3 CZ2015-896A CZ2015896A CZ2015896A3 CZ 2015896 A3 CZ2015896 A3 CZ 2015896A3 CZ 2015896 A CZ2015896 A CZ 2015896A CZ 2015896 A3 CZ2015896 A3 CZ 2015896A3
- Authority
- CZ
- Czechia
- Prior art keywords
- sacubitrile
- salts
- preparation
- solid forms
- propionyl
- Prior art date
Links
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Předmětem řešení jsou pevné formy volné kyseliny sacubitrilu vzorce I, zejména forma krystalická, včetně způsobu odstranění chemických nečistot ze surové volné kyseliny sacubitrilu, který se vyznačuje použitím dobře krystalujících solí sacubitrilu s aminy vzorce 9, kde R.sub.1.n., R.sub.2.n., R.sub.3.n.nezávisle na sobě značí vodík nebo alkyl C1-C7, s výhodou sůl s cyklohexylaminem, tert.butylaminem nebo iso-propylaminem. Řešení se dále týká vysoce efektivních a průmyslově využitelných způsobu přípravy pevné formy volné kyseliny sacubitrilu a jejích farmaceuticky využitelných solí, zejména krystalické sodné vzorce 5 a vápenaté soli sacubitrilu vzorce 6.The subject matter of the invention is the solid forms of the free acid of the sacubitrile of the formula I, in particular the crystalline form, including the method of removing chemical impurities from the crude free acid of the sacubitrile, characterized by the use of the well crystallizing salts of the sacubitrile with amines of the formula 9, independently of one another is hydrogen or C1-C7 alkyl, preferably a salt with cyclohexylamine, tert-butylamine or isopropylamine. The invention further relates to highly efficient and industrially useful processes for the preparation of the solid form of the free acid of sacubitrile and its pharmaceutically usable salts, in particular the crystalline sodium 5 and the calcium salt of the sacubitrile of formula 6.
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CZ2015-896A CZ2015896A3 (en) | 2015-12-14 | 2015-12-14 | The solid forms of the ethyl ester of (2R,4S)-5-(biphenyl-4-yl)-4-[3-carboxy-propionyl)amino]-2—methylpentanoic acid, its salts and the method of its preparation |
PCT/CZ2016/000130 WO2017097275A1 (en) | 2015-12-11 | 2016-12-12 | Solid forms of (2r,4s)-5-(biphenyl-4-yl)-4-[(3-carboxypropionyl)amino]-2- -methylpentanoic acid ethyl ester, its salts and a preparation method |
EP16818971.0A EP3386945A1 (en) | 2015-12-11 | 2016-12-12 | Solid forms of (2r,4s)-5-(biphenyl-4-yl)-4-[(3-carboxypropionyl)amino]-2- -methylpentanoic acid ethyl ester, its salts and a preparation method |
MX2018007129A MX2018007129A (en) | 2015-12-11 | 2016-12-12 | Solid forms of (2r,4s)-5-(biphenyl-4-yl)-4-[(3-carboxypropionyl)a mino]-2- -methylpentanoic acid ethyl ester, its salts and a preparation method. |
BR112018011788A BR112018011788A2 (en) | 2015-12-11 | 2016-12-12 | (2r, 4s) -5- (biphenyl-4-yl) -4 - [(3-carboxypropionyl) amino] -2-methylpentanoic acid ethyl ester solid forms, their salts and a preparation method |
ZA2018/03749A ZA201803749B (en) | 2015-12-11 | 2018-06-06 | Solid forms of (2r,4s)-5-(biphenyl-4-yl)-4-[(3-carboxypropionyl)amino]-2- -methylpentanoic acid ethyl ester, its salts and a preparation method |
CONC2018/0005941A CO2018005941A2 (en) | 2015-12-11 | 2018-06-12 | Solid forms of (2r, 4s) -5- (biphenyl-4-yl) -4 - [(3-carboxypropionyl) amino] -2-methyl-pentanoic acid ethyl ester, its salts and a preparation method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CZ2015-896A CZ2015896A3 (en) | 2015-12-14 | 2015-12-14 | The solid forms of the ethyl ester of (2R,4S)-5-(biphenyl-4-yl)-4-[3-carboxy-propionyl)amino]-2—methylpentanoic acid, its salts and the method of its preparation |
Publications (1)
Publication Number | Publication Date |
---|---|
CZ2015896A3 true CZ2015896A3 (en) | 2017-06-21 |
Family
ID=59249200
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CZ2015-896A CZ2015896A3 (en) | 2015-12-11 | 2015-12-14 | The solid forms of the ethyl ester of (2R,4S)-5-(biphenyl-4-yl)-4-[3-carboxy-propionyl)amino]-2—methylpentanoic acid, its salts and the method of its preparation |
Country Status (1)
Country | Link |
---|---|
CZ (1) | CZ2015896A3 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3766484A1 (en) | 2019-07-19 | 2021-01-20 | Zentiva, K.S. | Solid pharmaceutical dosage form comprising valsartan and sacubitril |
-
2015
- 2015-12-14 CZ CZ2015-896A patent/CZ2015896A3/en unknown
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3766484A1 (en) | 2019-07-19 | 2021-01-20 | Zentiva, K.S. | Solid pharmaceutical dosage form comprising valsartan and sacubitril |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112018011788A2 (en) | (2r, 4s) -5- (biphenyl-4-yl) -4 - [(3-carboxypropionyl) amino] -2-methylpentanoic acid ethyl ester solid forms, their salts and a preparation method | |
EA201992601A1 (en) | CONDENSED IMIDAZOPYPERIDINE COMPOUND, JAK INHIBITOR | |
EA201691401A1 (en) | INDASOLIC COMPOUNDS AS IRAK4 INHIBITORS | |
GEP20207105B (en) | 1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,1-trifluoro-4-hydroxybutan-2yl carbamate derivatives as magl inhibitors | |
PH12016501440A1 (en) | Novel heterocyclic compounds | |
MY176210A (en) | Process for the preparation of n-[(3-aminooxetan-3-yl)methyl]-2-(1,1-dioxo-3,5-dihydro-1,4-benzothiazepin-4-yl)-6-methyl-quinazolin-4-amine | |
MX2020011449A (en) | Oxysterols and methods of use thereof. | |
EA202091016A1 (en) | PYRIMIDINE COMPOUND AS A JAK KINASE INHIBITOR | |
EA202091505A1 (en) | Triazolazoles of Cyclohexyl Acid as LPA Antagonists | |
EA201791802A1 (en) | CROSSED DIHYDRO-4H-PYRAZOLO [5,1-c] [1,4] OXASYNYL COMPOUNDS AND ANALOGUES FOR THE TREATMENT OF CNS DISEASES | |
MY197698A (en) | Oxysterols and methods of use thereof | |
MX2016006199A (en) | Inhibitors of influenza viruses replication. | |
EA201300250A1 (en) | OXADIAZOL INHIBITORS OF LEUKOTRIEN PRODUCTION | |
PH12016501977A1 (en) | 2-AMINO-6-METHYL-4,4a,5,6-TETRAHYDROPYRANO[3,4-d][1,3]THIAZIN-8a(8H)-YL-1,3-THIAZOL-4-YL AMIDES | |
AR082968A1 (en) | BICYCLE INHIBITORS OF NOTUM PECTINACETILESTERASE AND A PHARMACEUTICAL COMPOSITION BASED ON THE COMPOUND | |
PH12017501422A1 (en) | 1-heterocyclyl isochromanyl compounds and analogs for treating cns disorders | |
PH12017501397A1 (en) | (2s, 4r)-5-(5`-chloro-2`-fluorobiphenyl-4-yl)-4-(ethoxyoxalylamino)-2-hydroxymethyl-2-methylpentanoic acid as neprilysin inhibitor | |
PH12018501876A1 (en) | Crystalline(2s,4r)-5-(5'-chloro-2'-fluoro-[1,1'-biphenyl]-4-yl)-2-(ethoxymethyl)-4-(3-hydroxyisoxazole-5-carboxamido)-2-methylpentanoic acid and uses thereof | |
MX2022000154A (en) | Alpha-amino esters of hydroxypropylthiazolidine carboxamide derivative and salt form, crystal polymorph thereof. | |
CZ2015896A3 (en) | The solid forms of the ethyl ester of (2R,4S)-5-(biphenyl-4-yl)-4-[3-carboxy-propionyl)amino]-2—methylpentanoic acid, its salts and the method of its preparation | |
EA201790522A1 (en) | SALT OF DERIVATIVE CEFALOSPORIN, ITS CRYSTAL SOLID MATTER AND METHOD OF ITS PREPARATION | |
PH12017500492A1 (en) | Crystalline bace inhibitors | |
EP3168215A3 (en) | Process for preparation of barnidipine | |
MX2009012704A (en) | Non-nucleoside reverse transcriptase inhibitors. | |
MX2018001548A (en) | A process for the preparation of the compound n-(3,5-dimethylphenyl)-n'-(2-trifluoromethylphenyl) guanidine. |